Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

REGISTER for free or LOG IN to view this content

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2
Cardiac Surgery
Structural Heart
Aortic Valve
Imaging & Physiology
CT/CT-FFR
Presentation
EuroPCR 2024

Up Next

More slides +

We Recommend